ROLE OF IRON IN TOXICITIES AND PATHOLOGIES
铁在毒性和病理学中的作用
基本信息
- 批准号:3253293
- 负责人:
- 金额:$ 12.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-05-01 至 1995-06-30
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis antioxidants autoradiography density gradient ultracentrifugation enzyme activity enzyme linked immunosorbent assay exopeptidase ferritin ferroxidase free radical oxygen gel filtration chromatography iron laboratory rat metal complex oxidation pathology peroxidation polymerase chain reaction superoxides toxicology western blottings
项目摘要
This proposal is to continue research on our proposal that iron is involved
in certain toxicities and pathologies. We have proposed that the iron
storage protein ferritin may be the source of this iron. Superoxide, and
especially organic radicals, release iron from ferritin. This iron will
catalyze the oxidation of tissues including lipid peroxidation. We propose
that this may be a mechanism by which chemicals that redox cycle may be
toxic. We also propose that ferritin may be a protective protein given an
efficient method to place the iron into ferritin. We propose that
ceruloplasmin may accomplish this as it is an effective ferroxidase which
does not release partially reduced species of oxygen such as hydrogen
peroxide. Thus, a combination of ferritin and ceruloplasmin may have
antioxidant activity. Evidence is mounting that ceruloplasmin is an
important intracellular, extrahepatic enzyme. We propose to further
investigate this hypothesis. We are also going to investigate the proposal
that both ferritin and ceruloplasmin may be induced by redox cycling
toxins. We also have to further investigate ferritin as we have found that
it differs in susceptibility to iron release by paraquat and adriamycin
depending upon the tissue from which it was isolated. We are proposing to
test the hypothesis that this is due to different content of heavy vs light
peptide chains. We also propose to test the hypothesis that some complex
may exist between ferritin and ceruloplasmin. Finally, we propose to
extend our research to investigate enzymes that have been proposed to have
"oxidase" activity. We will start with the enzyme gamma-glutamyl
transpeptidase. We propose that the products of the enzyme as it is
usually assayed are good iron reductants and that subsequent oxidation of
this iron is the source of the "oxidase" activity associated with this
enzyme. This iron is usually well controlled in physiological conditions
so the "oxidase" activity of gamma-glutamyl transpeptidase is probably not
of physiological significance except in unusual situations.
这个建议是继续研究我们的建议,铁参与
在某些毒性和病理学中。 我们建议铁
贮存蛋白铁蛋白可能是这种铁的来源。 超氧化物和
特别是有机自由基,从铁蛋白中释放铁。 这个钢铁意志
催化组织的氧化,包括脂质过氧化。 我们提出
这可能是一种机制,通过这种机制,
有毒 我们还提出,铁蛋白可能是一种保护性蛋白质,
将铁置于铁蛋白中的有效方法。 我们建议
血浆铜蓝蛋白可以实现这一点,因为它是一种有效的铁氧化酶,
不释放部分还原的氧物质如氢
过氧化物 因此,铁蛋白和血浆铜蓝蛋白的组合可具有
抗氧化活性 越来越多的证据表明,铜蓝蛋白是一种
重要细胞内、肝外酶。 我们建议进一步
调查这个假设。 我们也会调查
铁蛋白和铜蓝蛋白都可能是由氧化还原循环诱导的
毒素 我们还必须进一步研究铁蛋白,因为我们发现,
它对百草枯和阿霉素释放铁的敏感性不同
这取决于它所分离的组织。 我们建议
测试这是由于重质与轻质含量不同的假设
肽链 我们还建议测试假设,一些复杂的
可能存在于铁蛋白和铜蓝蛋白之间。 最后,我们建议
将我们的研究扩展到研究已经被提出具有
“氧化酶”活性。 我们将从γ-谷氨酰酶开始
转肽酶 我们认为酶的产物
通常测定的是良好的铁还原剂,
这种铁是与此相关的“氧化酶”活性的来源。
酵素 这种铁通常在生理条件下得到很好的控制
因此γ-谷氨酰转肽酶的“氧化酶”活性可能不是
除了在不寻常的情况下。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN D. AUST其他文献
STEVEN D. AUST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN D. AUST', 18)}}的其他基金
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)